The Potential Application of Large Language Models in Pharmaceutical Supply Chain Management.

The article informs about cystic fibrosis (CF) and its impact on airway health, focusing on the role of CFTR mutations in causing abnormal ion transport and subsequent lung complications. Topic include the approval of elexacaftor/tezacaftor/ivacaftor (ETI), a CFTR modulator therapy, and its potential to improve lung function in patients with CF, highlighting a retrospective analysis to determine its effect on Pseudomonas aeruginosa (PA) acquisition and chronic infection rates.